Feasibility Study to Evaluate the Observance Rehabilitation of Upper Limbs by Visual-motor Simulation Associated at Transcranial Direct Current Stimulation (tDCS) in Hemiparetic Patient Post-stroke
NCT ID: NCT03815266
Last Updated: 2023-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
9 participants
INTERVENTIONAL
2018-09-20
2022-04-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mirror Therapy Rehabilitation of the Upper Limb After Stroke (NEURO-MIROIR 2)
NCT04119544
Integration and Interactions Between Visual and Proprioceptive Feedbacks
NCT06931509
Evaluation of the Observance and the Tolerance of a Motor Training Program
NCT02844868
Comparison Study of 'Virtual Teacher' Support for Rehabilitation After Stroke.
NCT02234531
Mirror vs Virtual Reality Therapy for Upper Extremity Function in Hemiplegic Patients
NCT07018336
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient with first ischemic or hemorrhagic stroke
Patient with first ischemic or hemorrhagic stroke will be included. They will have the following program Computerized Mirror Therapy (CMT) associated at transcranial Direct Current Stimulation (tDCS). This program will consist of 5 sessions per week for 4 weeks (20 minutes).
In more, they will have the following tests: Tolerance Assessment Questionnaire, Ashworth's scale, Frenchay arm test, Abilhand questionnaire, Fugl-Meyer test, and Goal Attainment Scaling (GAS).
transcranial Direct Current Stimulation (tDCS)
transcranial Direct Current Stimulation (tDCS) is device which consist in setting up an electrode on the skull of the patient to deliver the low intensity current.
Patient will have transcranial Direct Current Stimulation (tDCS) at each session and at the same time of Computerized Mirror Therapy (CMT).
Computerized Mirror Therapy (CMT)
Computerized Mirror Therapy (CMT) will be realizing by the device Intensive Visual Simulation 3 (IVS3). Patient will have Computerized Mirror Therapy (CMT) at each session and at the same time of transcranial Direct Current Stimulation (tDCS).
Tolerance Assessment Questionnaire
The Tolerance Assessment Questionnaire will be completed at the end of each session.
Ashworth's scale
Ashworth's scale evaluates the resistance to stretching. This test will be completed before the start of the program, at the end of the program and one month after.
Frenchay arm test
Frenchay arm test evaluates your abilities with the affected hand to perform several actions.
This test will be completed before the start of the program, at the end of the program and one month after.
Abilhand questionnaire
Abilhand questionnaire evaluates your abilities to perform several activities in the daily life with your arm affected.
This test will be completed before the start of the program, at the end of the program and one month after.
Fugl-Meyer test
Fugl-Meyer test evaluates your ability to perform different movements with all the joints of your arm affected.
This test will be completed before the start of the program, at the end of the program and one month after.
Goal Attainment Scaling (GAS)
Goal Attainment Scaling (GAS) sets therapeutic goals with the patient before the start of the program.
These goals will be checked at the end of the program and one month after.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
transcranial Direct Current Stimulation (tDCS)
transcranial Direct Current Stimulation (tDCS) is device which consist in setting up an electrode on the skull of the patient to deliver the low intensity current.
Patient will have transcranial Direct Current Stimulation (tDCS) at each session and at the same time of Computerized Mirror Therapy (CMT).
Computerized Mirror Therapy (CMT)
Computerized Mirror Therapy (CMT) will be realizing by the device Intensive Visual Simulation 3 (IVS3). Patient will have Computerized Mirror Therapy (CMT) at each session and at the same time of transcranial Direct Current Stimulation (tDCS).
Tolerance Assessment Questionnaire
The Tolerance Assessment Questionnaire will be completed at the end of each session.
Ashworth's scale
Ashworth's scale evaluates the resistance to stretching. This test will be completed before the start of the program, at the end of the program and one month after.
Frenchay arm test
Frenchay arm test evaluates your abilities with the affected hand to perform several actions.
This test will be completed before the start of the program, at the end of the program and one month after.
Abilhand questionnaire
Abilhand questionnaire evaluates your abilities to perform several activities in the daily life with your arm affected.
This test will be completed before the start of the program, at the end of the program and one month after.
Fugl-Meyer test
Fugl-Meyer test evaluates your ability to perform different movements with all the joints of your arm affected.
This test will be completed before the start of the program, at the end of the program and one month after.
Goal Attainment Scaling (GAS)
Goal Attainment Scaling (GAS) sets therapeutic goals with the patient before the start of the program.
These goals will be checked at the end of the program and one month after.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Modified Frenchay arm test score \<70 (/ 100)
* Without a neurological history other than stroke
* Having signed the written consent and affiliated or entitled to a social security scheme
Exclusion Criteria
* Patient who didn't have cerebral Magnetic Resonance Imaging (MRI) imaging during their stroke
* With complete lesion of the primary motor cortex
* With alcohol / drug dependence
* With psychiatric illness, cognitive impairment, uncontrolled disease / epilepsy, malignant disease, severe renal or pulmonary disease
* With a history of disabling associated disease
* With cerebellar syndrome
* Pregnancy
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pascal GIRAUX, PhD
Role: PRINCIPAL_INVESTIGATOR
CHU SAINT-ETIENNE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Saint-Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A01883-52
Identifier Type: OTHER
Identifier Source: secondary_id
1708098
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.